Biotechnology

Pharmaceuticals company AbbVie, Inc. (NYSE: ABBV) on Wednesday reported an increase in revenue and adjusted earnings for the fourth quarter…

Business Overview Revvity, Inc. (NYSE: RVTY) operates through two primary business segments, Life Sciences and Diagnostics. The company provides instruments,…

Revvity, Inc. (NYSE: RVTY) shares closed at $108.80, up 0.29% on the day, after the company reported its fourth-quarter financial…

Johnson & Johnson (NYSE: JNJ) is capitalizing on its transition from a broad-based healthcare conglomerate into a market leader in…

IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance.…

Memory chipmaker Micron Technology Inc. (NASDAQ: MU) on Wednesday reported stronger-than-expected earnings for the first quarter of fiscal 2026. Revenue…

Pfizer Inc. (NYSE: PFE) has reaffirmed its earnings outlook for fiscal 2025 and revised revenue guidance. The pharma giant also…

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with…

CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat cancer, with a focus on…

Pharmaceuticals company Viatris Inc. (NASDAQ: VTRS) on Thursday reported financial results for the third quarter of fiscal 2025, and updated…

Pharmaceuticals company AbbVie, Inc. (NYSE: ABBV) on Friday reported a decline in earnings for the third quarter of fiscal 2025,…

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported an increase in adjusted profit for the third quarter of 2025 when its…

Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, reported a decline in adjusted earnings for the…

Thermo Fisher Scientific Inc. (NYSE: TMO) reported its third quarter 2025 earnings results today. Revenue grew 5% year-over-year to $11.12…

Kairos Pharma, Ltd. (NYSE: KAPA) is a biopharma company developing a pipeline of targeted therapies for cancer patients with high…

In recent months, Wall Street has seen a surge of healthcare firms seeking to go public, as IPO activity continues…

Profusa, Inc. (NASDAQ: PFSA) is a digital health company pioneering a new generation of biointegrated sensors. Its injectable biosensors are…

Eli Lilly and Company (NYSE: LLY) had a positive start to fiscal 2025, reporting strong revenue and earnings growth for…

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) on Thursday reported higher revenues and adjusted profit for the second quarter of 2025.…

Bristol Myers Squibb (NYSE: BMY) reported its second quarter 2025 earnings results today. Total revenues inched up 1% year-over-year to…

Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it…